Haemostasis is the prevention of unwanted blood loss; lean how this process works and is interrupted by blood-clotting and ...

Therefore, the researchers suggest discontinuing daprodustat to reduce the risk of recurrent ischemic strokes. Hypoxia-inducible factor prolyl hydroxylase (HIF-PH) inhibitors are ...

With a market cap of $2.67 billion, Geron Corporation (GERN) is a small-cap, commercial-stage biopharmaceutical company ...

An expert discussed the findings of the COMMANDS trial evaluating Reblozyl’s role in red blood cell transfusion independence ...

With FDA approval for imetelstat and solid financials, Geron shows great promise in MDS treatment. Read more on GERN stock ...

Chugai Pharmaceutical Co., Ltd., together with its subsidiaries, engages in the research, development, manufacture, sale, importation, and exportation of ...

It has been cleared for use in both non-dialysis-dependent (NDD) and dialysis-dependent (DD) CKD patients, providing an oral alternative to injectable erythropoiesis-stimulating agents (ESAs).

For patients with heart failure and reduced or mildly reduced left ventricular ejection fraction, iron deficiency is common and associated with more severe symptoms, worse quality of life and an ...